1. Chemotherapy Resistance
   Adrienne C. Scheck, 2018, Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy CrossRef
2. circ_PTN contributes to -cisplatin resistance in glioblastoma via PI3K/AKT signaling through the miR-542-3p/PIK3R3 pathway
   Hongcheng Luo et al, 2021, Molecular Therapy - Nucleic Acids CrossRef
3. Drug Delivery to Primary and Metastatic Brain Tumors: Challenges and Opportunities
   Surabhi Talele et al, 2022, Drug Delivery to the Brain CrossRef
4. Aldo-keto reductase 1B10 promotes development of cisplatin resistance in gastrointestinal cancer cells through down-regulating peroxisome proliferator-activated receptor-γ-dependent mechanism
   Toshiyuki Matsunaga et al, 2016, Chemico-Biological Interactions CrossRef
5. Candidate Urinary Biomarker Discovery in Gliomas
   Jianqiang Wu et al, 2019, Urine CrossRef
6. Peroxisome Proliferator-Activated Receptors (PPARs) and Oxidative Stress in Physiological Conditions and in Cancer
   Giuliana Muzio et al, 2021, Antioxidants CrossRef
7. ABCB1 and ABCG2 Regulation at the Blood-Brain Barrier: Potential New Targets to Improve Brain Drug Delivery
   Julia A. Schulz et al, 2023, Pharmacological Reviews CrossRef
8. High expression of autophagy-related gene EIF4EBP1 could promote tamoxifen resistance and predict poor prognosis in breast cancer
   Shan Yang et al, 2023, World Journal of Clinical Cases CrossRef
9. Drug Resistance in Glioblastoma: The Two Faces of Oxidative Stress
   Christophe Olivier et al, 2021, Frontiers in Molecular Biosciences CrossRef
10. The Mechanisms of Current Platinum Anticancer Drug Resistance in the Glioma
    Enzhou Lu et al, 2022, Current Pharmaceutical Design CrossRef